Mapping technological capabilities into product markets and competitive advantage: the case of cholesterol drugs
提出了一个模型，将企业技术能力转化为客户价值和竞争优势，并以胆固醇药物市场的实证数据展示其应用，适合研究能力部署与竞争战略的学者。
Abstract While a lot of attention has been paid to those characteristics of capabilities that give firms a competitive advantage, a lot less attention has been given to supporting empirical evidence and to the deployment of these capabilities. This paper presents a model for mapping firm capabilities into customer value and competitive advantage in different markets. With empirical evidence from cholesterol drugs, I illustrate how the model can be used to estimate customer value and competitive advantage from technological capabilities. Copyright © 2002 John Wiley & Sons, Ltd.